Jackson ImmunoResearch Laboratories

Jackson ImmunoResearch Laboratories

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Jackson ImmunoResearch is a long-established, privately held manufacturer of secondary antibodies and detection reagents for immunological research. The company has built a strong reputation over four decades for product reliability, consistency, and technical support, serving a global customer base through a direct and distributor network. Its business model is focused on the research tools and reagents sector, generating revenue from the sale of its extensive catalog of conjugated antibodies and streptavidin products. The company is ISO 9001:2015 certified, emphasizing its commitment to quality management.

Antibodies

Technology Platform

Specialized platform for antibody purification, cross-adsorption, and conjugation to enzymes, fluorophores, and other reporters. Includes novel single-domain VHH (nanobody) fragment antibody technology for high-resolution applications.

Opportunities

Growth is driven by the expanding life science research tools market and the adoption of advanced techniques requiring high-specificity reagents.
The company's innovative VHH antibody fragment platform creates opportunities in high-resolution imaging and niche applications where traditional antibodies underperform.
The bulk services program offers a direct path to serving large-scale industrial and core facility clients.

Risk Factors

The company faces intense competition from large, diversified life science suppliers and niche antibody producers, which could impact pricing and market share.
It is also exposed to supply chain risks for critical raw materials like host sera and specialty dyes.
Its focused portfolio on secondary antibodies represents a concentration risk if research trends shift away from these core methodologies.

Competitive Landscape

Jackson ImmunoResearch competes in the crowded research antibodies and reagents market. Its primary competitors include large conglomerates like Thermo Fisher Scientific, Abcam (now part of Danaher), and Bio-Rad, as well as specialized secondary antibody producers such as Vector Laboratories and Rockland Immunochemicals. Its competitive differentiation is built on a decades-long reputation for high specificity (through cross-adsorption), consistency, and deep technical support in the secondary antibody niche.